Scottish RA patients to get RoActemra while English patients wait
This article was originally published in Scrip
Executive Summary
The Scottish Medicines Consortium has accepted the use of Roche's RoActemra (tocilizumab) for some NHS Scotland patients with rheumatoid arthritis (RA). Meanwhile, patients in England and Wales are still waiting for a final decision from the National Institute of health and Clinical Excellence.